Stay updated on Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial

Sign up to get notified when there's something new on the Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision label changes from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-18T16:47:59.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The clinical trial record for vedolizumab with antiretroviral therapy in HIV-infected participants is displayed, with study design, eligibility, contacts, and outcome details.
    Difference
    48%
    Check dated 2026-11-11T17:46:58.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-10-28T15:55:02.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    A sitewide NIH notice was added, announcing updates to terminology around artificial intelligence during a transition period.
    Difference
    1%
    Check dated 2026-10-21T21:47:28.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changes from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-14T21:51:37.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision number changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-07T22:00:15.000Z thumbnail image

Stay in the know with updates to Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial page.